Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Operating Expenses | 7,122 | 7,154 | 7,203 | 6,285 | 11,055 |
Operating Income | -7,122 | -7,154 | -7,203 | -6,285 | -11,055 |
Other Income | 504 | 211 | 58 | 55 | 35 |
Pre-tax Income | -6,618 | -6,943 | -7,145 | -6,229 | -11,020 |
Net Income Continuous | -6,618 | -6,943 | -7,145 | -6,229 | -11,020 |
Net Income | $-6,618 | $-6,943 | $-7,145 | $-6,229 | $-11,020 |
EPS Basic Total Ops | -4.56 | -4.92 | -7.68 | -7.56 | -15.97 |
EPS Basic Continuous Ops | -4.62 | -4.87 | -7.67 | -7.46 | -15.98 |
EPS Diluted Total Ops | -4.56 | -4.92 | -7.68 | -7.56 | -15.97 |
EPS Diluted Continuous Ops | -4.62 | -4.87 | -7.67 | -7.46 | -15.98 |
EBITDA(a) | $-7,105 | $-7,137 | $-7,189 | $-6,278 | $-11,054 |